“Virtual clinical trial will change new drug development”
Drug development requires a lot of time and money.
It is true that most of drug candidates drop out before the market even though the candidate compounds go to human clinical trial after an animal testing and in-vitro experiment. That is because they have side effects or the expected drug effects are not achieved.
Sugiyama laboratory, started on April 2012, aims to establish “Virtual clinical trial” as an integrated support system for drug discovery and improve the success rate significantly to develop efficient drug discovery.